GYN – ASC Archived Cyto-econferences

 

GYNECOLOGY
Click on Item code or Item Name to purchase Archive


Archive Item Code: 3700-D

Item Name: Common and Challenging Pap Tests with Histopathologic Correlation and Management
Christine N. Booth, MD
Fadi W. Abdul-Karim, MD

Presentation date: July 28, 2015; Expires: July 28, 2018
This webinar will use case studies of common, yet challenging interpretations in gynecologic cytopathology to illustrate key cytomorphologic features of various disease processes. The cases will focus on Pap tests with follow-up histopathologic correlation when available. Knowledge of the Bethesda System for reporting cervical cytology is assumed. The updated 2012 ASCCP Consensus Management Guidelines will be covered to reflect the Pap test interpretations.

______________________________________________________________________________________________________________


Archive Item Code: 3700-A

Item Name: The Bethesda System in 2014: Updates for the Reporting of Gynecologic Cytology
Ritu Nayar, MD
David C. Wilbur, MD

Presentation date: April 28, 2015; Expires: April 28, 2018
In 2014, an ASC Task Force was convened to develop the 3rd addition of The Bethesda Atlas for the Reporting of Gynecologic C ytology. The group developed a series of questions related to each proposed chapter, which were presented on an internet bulletin board, receiving many comments and suggestions. These comments as well as an updated review of the literature provided the content for the new Atlas. A number of reporting recommendations have changed, but for the most part the terminology has remained the same as in the prior edition. The Atlas has however greatly expanded the content to include many new illustrations, particularly liquid-based, increased the rigor and description of morphologic criteria, added current management recommendations, updated the sections on ancillary testing and automated screening, and added a new chapter on risk assessment and how it is currently used in the development of evidence-based management guidelines. This webinar will highlight the changes and additions to the Atlas, and will present much of the updated morphologic criteria and the illustrations, which accompany them.

______________________________________________________________________________________________________________


Archive Item Code: 3600-A

Item Name: Pap Test Challenges from Coast to Coast
Michele A. Smith, MS, SCT(ASCP)
Kara Hansing, Med, SCT(ASCP)

Presentation date: April 22, 2014; Expires: April 22, 2017
Cytotechnologists from coast to coast have teamed up to provide challenging Pap Test cases. Review the unusual, the difficult, and the interesting Pap test dilemmas that we face every day or once in a lifetime. As we know, one challenge often leads to further challenges making the case even more difficult. Each case will be presented as they were submitted into the laboratory. Discussions of the challenge may include: morphology, molecular, collection, correlation, follow up, and regulatory guidelines.

______________________________________________________________________________________________________________


Archive Item Code: 3600-E

Item Name: Pap Test and HPV Correlation: The Value of Morphology
Barbara McGahey Frain, MS, CT(ASCP)

Presentation date: August 26, 2014; Expires: August 26, 2017
The focus of this archive will be a case-based approach to Pap Tests with expected, as well as unexpected high risk HPV results. Clinical/histologic follow up will be provided. Some unusual conditions will be addressed. Technical considerations and trouble-shooting based on one organization’s experience will be included.

______________________________________________________________________________________________________________


Archive Item Code: 3600-I

Item Name: Atypical Glandular Cells: Perils and Pitfalls in Cervicovaginal Cytology
Dina R. Mody, MD

Presentation date: December 9, 2014; Expires: December 9, 2017
This archive will demonstrate the glandular lesions of the cervix with its histologic correlates and pitfalls. Immunohistochemistry on cell blocks of liquid based specimens as well as tissue correlates will be demonstrated. Updates to Bethesda 2014 will be discussed.  Some newer concepts will be discussed time permitting.

______________________________________________________________________________________________________________


Archive Item Code: 3500-K

Item Name: Difficult Differential Diagnoses in GYN Cytology Secondary to Hormonal Influence
Michael R. Henry, MD

Presentation date: February 23, 2014; Expires: February 23, 2017
Cervical cytology varies tremendously depending on the hormonal status of the woman. This is especially true in the background of pregnancy (increased hormonal activity) or menopause (decreased hormonal activity). Increased or decreased levels of hormones create an environment, which affects the cervical mucosa and can lead to cellular changes that may be difficult to distinguish from true epithelial abnormalities.  This presentation addresses these issues with especial attention to atrophy versus HSIL and the epithelial changes seen in the background of pregnancy.

______________________________________________________________________________________________________________


Archive Item Code: 3500-I

Item Name: Glandular Lesions in Liquid Based Pap Tests:  Challenges of Hyperchromatic Crowded Groups
Donna K. Russell, MS, CT(ASCP)

Presentation date: December 10, 2013; Expires: December 10, 2016
Despite limitations of the Pap Test for detecting glandular abnormalities, the cytology of glandular epithelium in the female genital tract has assumed greater importance in recent years.  Improved sampling of the endocervical canal and an increase in the incidence of endocervical neoplasms has had an impact in detection of these lesions and their mimickers.  This webinar will provide an overview of benign, reactive, and neoplastic glandular lesions in liquid based preparations (both Thin Prep® and SurePath® preparations).  Pitfalls in glandular lesion diagnosis and patient management issues are highlighted.

______________________________________________________________________________________________________________


Archive Item Code: 3500-D

Item Name: Pap Tests and Clinical Consequences: OB-GYN Observations on Pap Results
Harvey Cramer, MD and Jeffrey Rothenberg, MD

Presentation date: July 23, 2013; Expires: July 23, 2016
In this presentation, an experienced gynecologist will discuss his perspectives on cervical cytology and outline clinical issues pertaining to cytology practice that most cytotechnologists and cytopathologists may not be aware of. Current cervical cytology screening guidelines, technical aspects of performing a pelvic examination and Pap smear procurement and the therapeutic ramifications of the various cytologic diagnoses as well as his personal perspectives on the use of HPV testing will be discussed. Comments regarding the cytomorphologic aspects of the cases being presented will be provided by the cytopathologist. The value of close interaction between clinician and cytopathologist is strongly emphasized.

______________________________________________________________________________________________________________


Archive Item Code: 3400-D

Item Name: Workload Limits and Quality Assurance in Image-assisted Gynecologic Screening
Tarik M. Elsheikh, MD

Presentation date: July 24, 2012; Expires: July 24, 2015
With the current and projected shortage of the cytotechnologist workforce and desires to reduce laboratory costs, markedly increased productivity with image assisted screening, not necessarily increased sensitivity, became an attractive option for many labs. This may be accomplished by imposing pre-determined productivity quota, and reducing QA measures to the minimum required by CLIA. More recent literature, however, has shown that the FDA approved cytotechnologist workload limits are too high and can lead to increased error rate, and that the CLIA-mandated quality measures, by themselves, may fail to detect poor cytotechnologist performers. In this webinar, review of recent literature and recommendations for cytotechnologist workload limits and QA measures are presented.

________________________________________________________________________________________________________________________________